These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3579518)

  • 1. Hydroxy substituted 10-ethyl-9-phenylphenanthrenes: compounds for the investigation of the influence of E,Z-isomerization on the biological properties of mammary tumor inhibiting 1.1.2.-triphenylbutenes.
    Schneider MR; Schiller CD
    Arch Pharm (Weinheim); 1987 Feb; 320(2):159-66. PubMed ID: 3579518
    [No Abstract]   [Full Text] [Related]  

  • 2. 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties.
    Schneider MR; von Angerer E; Schönenberger H; Michel RT; Fortmeyer HP
    J Med Chem; 1982 Sep; 25(9):1070-7. PubMed ID: 6813499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted phenanthrenes with basic amino side chains: a new series of anti-breast cancer agents.
    Shagufta ; Srivastava AK; Sharma R; Mishra R; Balapure AK; Murthy PS; Panda G
    Bioorg Med Chem; 2006 Mar; 14(5):1497-505. PubMed ID: 16249093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental tumor inhibitors. Antitumor acitivity of esters of omega-aryl-psi-nitro-psi-alken-1-ol and related compounds.
    Zee-Cheng KY; Cheng CC
    J Med Chem; 1969 Jan; 12(1):157-61. PubMed ID: 5763013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synthesis of diaryl-2- and -3-hexenes (author's transl)].
    Hamacher H; Brecht B
    Arch Pharm (Weinheim); 1977 Aug; 310(8):662-74. PubMed ID: 921502
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxic estrogens: anilin mustard linked 1,1,2-triphenylbut-1-enes with mammary tumor inhibiting activity.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1989 Jan; 322(1):59-62. PubMed ID: 2730288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-[4-(N,N-bis-beta-chloroethylcarbamoyloxy)-phenyl]-1,2-bis- (hydroxyphenyl)-but-1-enes: drugs specifically targeted against estrogen receptor positive mammary tumors.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1990 Apr; 323(4):215-9. PubMed ID: 2360864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of derivatisation of the hydroxy groups in 1,1-bis-(4-hydroxyphenyl)-2-phenylbut-1-ene on estradiol receptor affinity and mammary tumor inhibiting properties.
    Schuderer ML; Schneider MR
    Arch Pharm (Weinheim); 1987 Jul; 320(7):635-41. PubMed ID: 3675160
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetoxy substituted 1,1,2-triphenylbut-1-enes: estrogenic, antiestrogenic and mammary tumor inhibiting activity.
    Schneider MR
    J Cancer Res Clin Oncol; 1986; 112(2):119-24. PubMed ID: 3771620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.
    Schneider MR; Ball H; Schönenberger H
    J Med Chem; 1985 Dec; 28(12):1880-5. PubMed ID: 4068009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New synthetic cytotoxic and antitumoral agents derived from aristolochic acid, an antitumoral nitrophenanthrenic acid extracted from Aristolochiaceae].
    Viel C; Doré JC
    Farmaco Sci; 1972 Apr; 27(4):257-312. PubMed ID: 5023999
    [No Abstract]   [Full Text] [Related]  

  • 12. Catechol estrogens of the 1,1,2-triphenylbut-1-ene type: relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities.
    Schneider MR; Ball H; Schiller CD
    J Med Chem; 1986 Aug; 29(8):1355-62. PubMed ID: 3016262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, Part III: Evaluation of the mammary tumor inhibiting properties.
    Schertl S; Gust R; Müller R; Spruss T; Schönenberger H
    Arch Pharm (Weinheim); 1992 Feb; 325(2):113-8. PubMed ID: 1605715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic cinnamylphenol derivatives as cancer chemopreventive agents.
    Ito C; Itoigawa M; Kanematsu T; Imamura Y; Tokuda H; Nishino H; Furukawa H
    Eur J Med Chem; 2007 Jul; 42(7):902-9. PubMed ID: 17316910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary tumor inhibiting properties of the (S,S)-configurated [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complex.
    Spruss T; Gust R; Müller R; Engel J; Schönenberger H
    Arch Pharm (Weinheim); 1990 Feb; 323(2):99-102. PubMed ID: 2334275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitors of aromatase. Synthesis and pharmacologic action of potential mammary tumor-inhibiting 4-alkyl-3-(4-aminophenyl)-3-ethylpiperidine-2,6-diones].
    Batzl C; Hartmann RW
    Arch Pharm (Weinheim); 1987 Jan; 320(1):51-8. PubMed ID: 3566486
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes, III: Evaluation of the mammary tumor inhibiting properties.
    Reile H; Spruss T; Müller R; Gust R; Bernhardt G; Schönenberger H; Engel J
    Arch Pharm (Weinheim); 1990 May; 323(5):301-6. PubMed ID: 2383173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the antitumor activity of podocarpic acid derivatives.
    Parish EJ; Miles DH
    J Pharm Sci; 1984 May; 73(5):694-6. PubMed ID: 6737247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cytotoxicity of 1-phenyl-3,3-diacetoxy-1-propene.
    Dimmock JR; Kumar P; Jha A; Quail JW
    Pharmazie; 2001 Sep; 56(9):744-5. PubMed ID: 11593998
    [No Abstract]   [Full Text] [Related]  

  • 20. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.
    Schneider MR
    J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.